Skip to main content

Advertisement

SpringerLink
Log in

A novel IT infrastructure for reverse logistics operations of end-of-life pharmaceutical products

  • Published:
Information Technology and Management Aims and scope Submit manuscript

Abstract

End-of-life (EOL) is a term used to indicate that a product has completed its service lifetime and has reached the end of its useful life. A number of reasons can cause the product to complete its service life time including deterioration or obsolescence. Deterioration implies that the performance and hence the reliability of the product has significantly lessened making it no longer suitable for use due to disintegration or degeneration. Obsolescence is often used to describe the products that are rendered invalid due to systemic, functional, and style mismatch or due to notification of expiration. Lack of deterioration implies that the obsolete products are likely to preserve their functionality. The duration of shelf life varies due to numerous product-specific factors for each product. Prescription drugs, a major product class in drugs and pharmaceuticals, are one product category that is likely to complete its service life time prior to deterioration. The gap between the shelf life and the actual obsolescence date leads to storage or disposal of growing number of EOL pharmaceutical products. This fact, coupled with the significant hazard potential of these products require a well-established reverse logistics system capable of handling EOL operations such as take back, reuse, recycle, and proper disposal of these products. With these motivations, this study proposes a reverse logistics framework that embodies environmental, economical, and physical concerns for EOL pharmaceutical products. An radio frequency identification-based information technology infrastructure for the proposed system along with a comprehensive overview of the existing drug take-back regulations worldwide is also provided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Mueller DB et al (2007) Service lifetimes of mineral end uses. Report. USGS award number, November 2007. USGS

  2. Leslie DL, Rosenheck RA (2002) From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications. Am J Psychiatr 159(9):1534–1540

    Article  Google Scholar 

  3. Pomerantz JM (2004) Recycling expensive medication: Why not? http://www.ncbi.nlm.nih.gov

  4. Sartori G (2010) Reverse logistics role in securing the pharmaceutical supply chain. 28 Sep 2010, 16. http://www.rlmagazine.com/edition16p18.php

  5. Kümmerer K (2010) Pharmaceuticals in the environment. Annu Rev Environ Resour 35(1):57

    Article  Google Scholar 

  6. CMS (2012) Center for medicare and medicaid services

  7. CEBS (2012) Health care economics and issues. C.E.B.S. Program, Editor. Canadian Institute for Health Information, Ottawa, ON, Canada, pp 2–45

  8. WHO (2012) Global health expenditure database. World Health Organization

  9. OECD (2012) OECD health data 2012. The Organization of Economic Cooperation and Development

  10. OECD, H.D. (2010) Health expenditure and financing. In: Health at a glance: Europe 2010. OECD Publishing, pp 104–106

  11. Hu T-L, Sheu J-B, Huang K-H (2002) A reverse logistics cost minimization model for the treatment of hazardous wastes. Transp Res Part E Logist Transp Rev 38(6):457–473

    Article  Google Scholar 

  12. Valero G (2005) Logistics in reverse. www.pbsmag.com/Article.cfm?ID

  13. Hunter T et al (2005) Effectively managing pharmaceutical returns and waste. Drug Topics 149(2):36

    Google Scholar 

  14. Martin P (2007) “Reverse logistics in pharma industry”, the remanufacturing gazette magazine. http://remannews.blogspot.com/2007/03/reverse-logisticsin-pharma-industry.html

  15. Teunter R et al (2003) Reverse logistics in a pharmaceutical company: a case study. Econometric Institute Report

  16. Cross C (2007) A hard sell: Carolina Logistics Services reverses the route of controlled substances. Ind Eng 39(5):24

    Google Scholar 

  17. Nsimba SED (2008) Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of anti-retroviral (Arvs) drugs in a free market economy. East Afr J Public Health 5(3):205–210

    Google Scholar 

  18. Pollinger ZA (2008) Counterfeit goods and their potential financing of international terrorism. Michigan J Bus 1(1):85–102

  19. ICE (2012) News releases: man convicted for role in international counterfeit drug distribution scheme search continues for organization’s ringleader, D.o.H. Security, Editor. US Immigration and Customs Enforcement

  20. Kumar S (2009) Reverse logistic process control measures for the pharmaceutical industry supply chain. Int J Product Perform Manag 58(2):188

    Article  Google Scholar 

  21. Lee CKM, Chan TM (2009) Development of RFID-based reverse logistics system. Expert Syst Appl 36(5):9299–9307

    Article  Google Scholar 

  22. Howard J (2009) Implementation of RFID in the pharmaceutical industry. California Polytechnic State University, San Luis Obispo, CA

    Google Scholar 

  23. Ahsan K (2011) RFID components, applications and system integration with healthcare perspective. Deploying RFID—challenges, solutions, and open issues

  24. Cohen LP (2000) Safe and effective: many medicines prove potent for years past their expiration dates. Wall Str J. http://www.terrierman.com/antibiotics-WSJ.htm

  25. NCSL (2010) State prescription drug return, reuse and recycling laws. http://www.ncsl.org/IssuesResearch/Health/StatePrescriptionDrugReturnReuseandRecyclin/tabid/14425/Default.aspx

  26. DOH (2007) Drugs and medical supply repository stud, D.o. Health, Editor. Vermont Department of Health, Agency of Human Services

  27. USGA (2011) Environmental health: action needed to sustain agencies’ collaboration on pharmaceuticals in drinking water, U.S.G.A. Office, Editor. Washington, DC

  28. Fryer M (2010) Pennsylvania Senate Oks bill allowing jails to recycle unused medicine. Leader Times, Pittsburgh

    Google Scholar 

  29. Grasso C (2009) Secure medicine return in Washington state, the PH: ARM pilot. In: Pharmaceuticals from households: a return mechanism

  30. CalRecycle (2013) Report to the legislature: recommendations for home-generated pharmaceutical collection programs in California, C.D.o.R.R.a. Recovery, Editor

  31. Cotter P (2010) Drug takeback programs—national day planned. http://www.naag.org/drug-takeback-programs-national-day-planned.php

  32. The Drug Take Back Network (2010). http://www.naag.org/drug-takeback-programs-national-day-planned.php

  33. Stericycle (2010) Rx waste disposal. http://www.stericycle.com/rx-waste-disposal.html

  34. Glassmeyer ST (2009) Disposal practices for unwanted residential medications in the United States. Environ Int 35(3):566

    Article  Google Scholar 

  35. Canada, S (2009) Analysis: leftover or expired medication. http://www.statcan.gc.ca/pub/11-526-x/2011001/part-partie1-eng.htm

  36. Gagnon E (2009) Pharmaceutical disposal programs for the public: a Canadian perspective, H. Canada, Editors, Environmental Impact Initiative, p 84

  37. J MacDonnell Pharmacy Ltd. (2009) Review and recommendations on effective disposal of unused medications and used sharps. J. MacDonnell Pharmacy Ltd., p 83

  38. Product Stewardship Institute, Inc. (2012) Protecting our health and the environment: the need for sustainably financed drug take-back programs. Product Stewardship Institute, Inc. University of Wisconsin, p 19

  39. Campbell J, Halasi S, James LJ (2010) Management of post-consumer pharmaceutical waste. Canadian Healthcare Network

  40. Cyclamed (2012) Summary: English. http://www.cyclamed.org/index.php?page=article&article=11&PHPSESSID=5a16e35b7a5d93319a05000af9e91ea6

  41. Marques RC et al (2011) Framework and evolution of the packaging sector in Portugal. Technical University of Lisbon, EIMPack-Economic Impact of the Packaging and Packaging Waste Directive, p 32

  42. PCPSA (2011) Post-Consumer Pharmaceutical Stewardship Association (PCPSA). Annual Report. Manitoba Medications Return Program

  43. European Union Commission (2011) Technical assistance for development of a national environmental approximation strategy (EAS) for the Republic of Serbia

  44. Bureau, U.S.C. (2011) Population 60 years and over in the United States. http://factfinder2.census.gov/faces/services/jsf/pages/productview.xhtml?pid=ACS_11_1YR_S0102&prodType=table

  45. CalRecyle (2010) Report to the legislature: recommendations for home-generated pharmaceutical collection programs in California. California Department of Resources Recycling and Recovery

  46. Canada, S (2012) Population by year, by province and territory

  47. CIA (2012) The world fact book. https://www.cia.gov/library/publications/the-world-factbook/geos

  48. GAO (2011) Environmental health: action needed to sustain agencies’ collaboration on pharmaceuticals in drinking water, U.S.G.A. Office, Editor. United States Government Accountability Office, Washington, DC, p 57

  49. Grasso C (2009) Secure medicine return in Washington State. The PH: ARM Pilot

  50. Takahashi, Y. (2010) Waste drug collection and disposal program at pharmacies. In 130th Annual Meeting of the Pharmaceutical Society of Japan, Yokohama Pharmaceutical Association

  51. Yokohama C.o. (2012) About Yokohama. http://www.city.yokohama.lg.jp/keizai/yuchi/sinsyutu-e/ab-yoko.html

  52. Lubick M (2010) Drugs in the environment: do pharmaceutical take-back programs make a difference? Environ Health Perspect 118(5):210–214

    Article  Google Scholar 

  53. Lobo C (2011) Medicines: a health and economic burden and an abandoned reality. Off News Tech J Int Soc Pharmacoeconomics Outcomes Res

  54. ISJ (2014) Unwanted prescription drugs can be discarded at environmental fair this saturday

  55. Gualtero SM (2005) Pollution prevention measures for unwanted pharmaceuticals. Ind Ecol. http://www.seas.columbia.edu/earth/wtert/sofos/Gualtero_IETerm_.pdf

  56. Castro L, Wamba S (2007) An inside look at RFID technology. J Technol Manag Innov 2(1):150–200

    Google Scholar 

  57. FDEP (2014) How to dispose of unwanted medications

  58. Schendel S , McClure R (2012) Drug companies fight take-back program for unused medicine. http://www.invw.org/content/drug-companies-fight-take-back

  59. Attaran M (2007) RFID: an enabler of supply chain operations. Supply Chain Manag Int J 12(4):249–257

    Article  Google Scholar 

  60. Mireles M (2007) Unused and expired medicines: a national pandemic. Symbiosis 4(2):40–42. http://www.teleosis.org/pdf/symbiosis/UEM4.2.pdf

  61. Thomas MW (2014) City collecting unwanted drugs for safe disposal. San Antonio Bus J. http://www.bizjournals.com/sanantonio/blog/2014/02/city-collecting-unwanted-drugs-for-safe-disposal.html

  62. Jesson J, Pocock R, Wilson K (2005) Reducing medicines waste in the community. Prim Health Care Res Dev 6(5):117–124

    Article  Google Scholar 

  63. Lee CKM, Chan TM (2009) Development of RFID-based reverse logistics system. Expert Syst Appl 36:9299–9307

    Article  Google Scholar 

  64. Lee CKM et al (2011) Design and development of logistics workflow systems for demand management with RFID. Expert Syst Appl 38:5428–5437

    Article  Google Scholar 

  65. Visich JK, Li SH, Khumawala BM (2007) Enhancing product recovery value in closed-loop supply chains with RFID. J Manag Iss 19(3):436–452

    Google Scholar 

  66. Trappey AJC, Trappey CV, Wu CR (2010) Genetic algorithm dynamic performance evaluation for RFID reverse logistic management. Expert Syst Appl 37:7329–7335

    Article  Google Scholar 

  67. Guide VDR Jr et al (2006) Time value of commercial product returns. Manage Sci 52(8):1200–1214

    Article  Google Scholar 

  68. Schultmann F, Zumkeller M, Rentz O (2006) Modeling reverse logistics tasks within closed-loop supply chains: an example from the automotive industry. Eur J Oper Res 171(3):1033–1050

    Article  Google Scholar 

  69. Poon TC et al (2009) A RFID case-based logistics resource management system for managing order-picking operations in warehouses. Expert Syst Appl 36:8277–8301

    Article  Google Scholar 

  70. Langer N et al (2007) Assessing the impact of RFID on return center logistics. Interfaces 37(6):501–514

    Article  Google Scholar 

  71. Kongar E, Gupta SM (2009) Solving the disassembly-to-order problem using linear physical programming. Int J Math Oper Res (IJMOR) 1(4):504–531

    Article  Google Scholar 

  72. Teleosis Institute (2007) Green pharmacy program—preliminary data report. Teleosis Institute, Berkeley, CA

  73. Siler S et al (2009) Safe disposal of unused controlled substances. King Pharmaceuticals, Inc

  74. Schatteman O (2003) Reverse logistics. Gower handbook of supply chain management, p 267

  75. Tibben-Lembke R, Rogers D (1998) Size and importance of reverse logistics. In: Going backwards: reverse logistics. Trends and Practices. Reverse Logistics Executive Council p 281

  76. Matičević G, Čičak M, Lovrić T (2011) RFID and supply chain management for manufacturing digital enterprise. In: Renko S (ed) Supply chain management—new perspectives. doi:10.5772/18625

  77. Chen M (2006) The enterprise value analysis based on reverse logistics

  78. IBM, C (2007) IBM solution for pharmaceutical track and trace. ibm.com/solutions/rfid

  79. Want R (2006) An introduction to RFID technology. Pervasive Comput IEEE 5(1):25–33

    Article  Google Scholar 

  80. Asif R (2011) Reverse logistics: RFID the key to optimality. J Ind Eng Manag 4(2):281–300

  81. Sharps Compliance, Inc (2009) Unused patient medication disposal. Sharps Compliance, Inc

  82. Martineau B (2014) Unwanted pharmaceuticals take back, D.o.E. Conservation, Editor

  83. Select USA (2014) The pharmaceutical and biotech industries in the United States, U.D.o. Commerce, Editor. http://selectusa.commerce.gov/industry-snapshots/pharmaceutical-industry-united-states

  84. Frontières MS, Frontières PS (1999) Guidelines for safe disposal of unwanted pharmaceuticals in and after emergencies. World Health Organization

  85. Prüss A, Giroult E, Rushbrook P (1999) Safe management of wastes from health-care activities. World Health Organization (WHO)

  86. WHO (2012) Quality assurance of pharmaceuticals: a compendium of guidelines and related materials. World Health Organization

Download references

Author information

Authors and Affiliations

  1. Departments of Mechanical Engineering and Technology Management, School of Engineering, University of Bridgeport, 221 University Avenue, 141 Technology Building, Bridgeport, CT, 06604, USA

    Elif Kongar

  2. Intertech Information Technology and Marketing Inc., Istanbul, 34394, Turkey

    Ece Haznedaroglu

  3. Investigational Drug Service, Yale-New Haven Hospital, New Haven, CT, USA

    Osama Abdelghany

  4. Yale University School of Medicine, 333 Cedar Street, P.O. Box 208063, New Haven, CT, 06520-8063, USA

    Mert Ozan Bahtiyar

Authors
  1. Elif Kongar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ece Haznedaroglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Osama Abdelghany
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mert Ozan Bahtiyar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elif Kongar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kongar, E., Haznedaroglu, E., Abdelghany, O. et al. A novel IT infrastructure for reverse logistics operations of end-of-life pharmaceutical products. Inf Technol Manag 16, 51–65 (2015). https://doi.org/10.1007/s10799-014-0195-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10799-014-0195-z

Keywords

Search

Navigation